Cargando…

COVID‐19 associated EBV reactivation and effects of ganciclovir treatment

BACKGROUND: Systemic reactivation of Epstein–Barr virus (EBV) may occur in novel coronavirus disease 2019 (COVID‐19) caused by the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). However, the clinical consequences of EBV reactivation remain uncertain. METHODS: In this retrospective stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Mei, Zhang, Sheng, Dong, Xuan, Sun, Wenqing, Deng, Yunfeng, Li, Wenzhe, Li, Ranran, Annane, Djillali, Wu, Zhixiong, Chen, Dechang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959425/ https://www.ncbi.nlm.nih.gov/pubmed/35349757 http://dx.doi.org/10.1002/iid3.597

Ejemplares similares

Corticosteroid treatment in severe patients with SARS-CoV-2 and chronic HBV co-infection: a retrospective multicenter study
por: Meng, Mei, et al.
Publicado: (2022)

Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients
por: Meng, Mei, et al.
Publicado: (2021)

Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation
por: Papazian, Laurent, et al.
Publicado: (2021)

Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study
por: Liu, Jiao, et al.
Publicado: (2021)

Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study
por: Liu, Jiao, et al.
Publicado: (2021)

Topical ganciclovir in the treatment of acute herpetic keratitis
por: Tabbara, Khalid F, et al.
Publicado: (2010)

2% Ganciclovir Eye Drops Control Posner-Schlossman Syndrome Relapses With/Without Cytomegalovirus Intraocular Reactivation
por: Sheng, Qilian, et al.
Publicado: (2022)

Ganciclovir/letermovir: Rebound Cytomegalovirus hepatitis, acquired resistance to ganciclovir and nephrotoxicity: case report
Publicado: (2020)

A desensitization protocol to ganciclovir
por: Cernadas, Josefina Rodrigues, et al.
Publicado: (2014)

Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis
por: Wu, Chung-Chun, et al.
Publicado: (2019)

Sepsis-associated delirium: the pro and con of C5a blockade
por: Annane, Djillali
Publicado: (2009)

Critical Care Handbook of the Massachusetts General Hospital
por: Annane, Djillali
Publicado: (2011)

Corticosteroids for severe sepsis: an evidence-based guide for physicians
por: Annane, Djillali
Publicado: (2011)

Corticosteroids for sepsis: registry versus Cochrane systematic review!
por: Annane, Djillali
Publicado: (2010)

Cortisol replacement for severe sepsis and septic shock: what should I do?
por: Annane, Djillali
Publicado: (2002)

The Role of ACTH and Corticosteroids for Sepsis and Septic Shock: An Update
por: Annane, Djillali
Publicado: (2016)

Corticosteroids for COVID-19
por: Annane, Djillali
Publicado: (2021)

The pandemic in French intensive care units—Author's response
por: Annane, Djillali
Publicado: (2021)

From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity
por: Kanduc, Darja, et al.
Publicado: (2020)

Crystallization after intravitreal ganciclovir injection
por: Choopong, Pitipol, et al.
Publicado: (2010)

EBV reactivation as a target of luteolin to repress NPC tumorigenesis
por: Wu, Chung-Chun, et al.
Publicado: (2016)

Therapeutic strategies for critically ill patients with COVID-19
por: Li, Lei, et al.
Publicado: (2020)

Treatment outcomes of reduced-dose intravitreal ganciclovir for cytomegalovirus retinitis
por: Choopong, Pitipol, et al.
Publicado: (2016)

Two possible mechanisms of ganciclovir for treatment of major depressive disorder
por: Itoh, Kazuhiro, et al.
Publicado: (2023)

Population Pharmacokinetics and Dose Optimization of Ganciclovir in Critically Ill Children
por: Li, SiChan, et al.
Publicado: (2021)

Retinal and Corneal Toxicity and Pharmacokinetic Analysis of Intraocular Injection of Ganciclovir in Rabbit Eyes
por: Sun, Bin-jia, et al.
Publicado: (2019)

Clinical Efficacy of Oral Ganciclovir for Prophylaxis and Treatment of Recurrent Herpes Simplex Keratitis
por: Wang, Xin, et al.
Publicado: (2015)

Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas
por: Ramayanti, Octavia, et al.
Publicado: (2018)

Epstein–Barr Virus (EBV) Rta-Mediated EBV and Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivations in 293 Cells
por: Chen, Yen-Ju, et al.
Publicado: (2011)

A Case of Severe Ganciclovir-Induced Encephalopathy
por: Sakamoto, Hikaru, et al.
Publicado: (2013)

Ganciclovir-resistant cytomegalovirus infection in renal transplantation
por: Vaz, Raquel, et al.
Publicado: (2014)

Ganciclovir use evaluation in kidney transplantation departments
por: Mozaffar, Maryam, et al.
Publicado: (2016)

Ganciclovir therapeutic drug monitoring in transplant recipients
por: Märtson, Anne-Grete, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Ganciclovir: Where Are We?
por: Märtson, Anne-Grete, et al.
Publicado: (2022)

Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma
por: Choi, Su Jin, et al.
Publicado: (2019)

Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells
por: Yin, Qinyan, et al.
Publicado: (2017)

Intracranial abscess developed after ganciclovir treatment: A case report
por: Cansever, Murat, et al.
Publicado: (2018)

Acute Kidney Injury in the ICU during Ganciclovir Treatment, an Observational Study
por: Al Fartousi, Mina, et al.
Publicado: (2023)

Association of sex with clinical outcomes in COVID-19 patients: A retrospective analysis of 1190 cases
por: Liu, Jiao, et al.
Publicado: (2020)

Complement Inhibition and COVID-19: The Story so Far
por: Fodil, Sofiane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ec4gl4b00a90rq408t2kdht50p